drugset / Trial / NCT03097627
Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions
NaSingle-groupOpen-labelDevice feasibility
Summary
This is a clinical trial to evaluate the intravenous administration of indocyanine green (ICG) as a method of intra-thoracic lesion localization. The primary purpose is to determine if intravenous ICG allows us to identify intra-thoracic lesions.
Timeline
- Start
- 2016-02-01
- Primary completion
- 2016-10-28
- Completion
- 2016-10-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.5 mg/kg | Intravenous |